On Oct. 14 2007, Medtronic Inc. announced that it was voluntarily withdrawing from the market its Sprint Fidelis heart defibrillator leads because of the potential for lead fractures. When these leads, or electronic wires, fracture, they can cause defibrillators to administer unnecessary shocks or to stop working completely. The company estimates that approximately 268,000 of its Sprint Fidelis leads have been implanted into patients.

The market withdrawal was prompted by reports of five deaths as well as other patient health complications that may be linked to malfunctioning Sprint Fidelis leads. Health care facilities with these devices still on their shelves are being advised to return them to Medtronic, although the company advises that patients who have been implanted with the leads should retain them due to the risks associated with removal.

If you or someone you know has been injured by a Medtronic Sprint Fidelis contact our office right away.  Let our experienced team of attorneys properly evaluate your case. 619.615.0767